source
- Biogen's litifilimab shows clear or almost clear skin in cutaneous lupus after one yearBiogen reported that its experimental antibody litifilimab produced clear or almost clear skin in patients with cutaneous lupus erythematosus after one year of treatment in a mid‑stage study. The r…
- Kyverna Therapeutics reports encouraging data for first CAR-T therapy targeting autoimmune diseaseKyverna Therapeutics released new data that strengthens its case for bringing the first CAR‑T treatment for an autoimmune condition to market. The results come after recent safety setbacks in simil…